(Q64961811)
Statements
Clinical and cerebrospinal fluid changes in parkinsonian patients treated with L-3,4-dihydroxyphenylalanine (L-dopa) (English)
Clinical and cerebrospinal fluid changes in parkinsonian patients treated with L‐3, 4‐dihydroxyphenylalanine (L‐dopa) (English)
1 reference
N. S. Sharpless
A. D. Ericsson